Tufts University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Tufts University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013578
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tufts University (Tufts) is an educational and research university that offers undergraduate and postgraduate courses in various fields. The university offer courses in anthropology, applied mathematics, architectural engineering, physics, archaeology, Asian American studies, biochemistry, biomedical engineering, economics, child study and human development, cognitive and brain sciences, food systems and nutrition, geological sciences, philosophy, medieval studies, music and political science among others. It works with other institutes to conduct research on antibiotic resistance, cholera, HIV and lyme disease, and other pressing health issues. Tufts undertakes technology transfer for commercial development. It operates through various schools and colleges located across Massachusetts, the US. Tufts University is headquartered in Medford, Massachusetts, the US.

Tufts University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tufts University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tufts University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tufts University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tufts University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tufts University, Medical Devices Deals, 2011 to YTD 2017 9
Tufts University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tufts University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Tracon Pharma Enters into Research Agreement with Tufts Medical Center 11
Tufts Medical Center to Form Joint Venture with Lowell General Hospital 13
Tufts Medical Center Forms Joint Venture with Aton Partners 14
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 15
Tufts Medical Center, Vanguard Health And New England Quality Care Partner For New Healthcare System 16
Licensing Agreements 17
Arisaph Pharma Enters into Licensing Agreement with Tufts University 17
GliaCure Enters into Licensing Agreement with Tufts University 18
Debt Offering 19
Tufts Medical Center Announces Public Offering Of Bonds For US$100 Million 19
Tufts University – Key Competitors 20
Tufts University – Key Employees 21
Tufts University – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Government and Public Interest 23
Sep 13, 2016: New technique generates human neural stem cells for tissue engineering, 3D brain models 23
Apr 12, 2016: Scientists reveal new target for anti-lymphangiogenesis drugs 24
Mar 16, 2016: Researchers Prevent, Normalize Tumors Using Light to Control Cell Electric Signals 25
Feb 10, 2016: Faulty bioelectric signal responsible for facial defects caused by rare genetic disorder 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Tufts University, Pharmaceuticals & Healthcare, Key Facts 2
Tufts University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tufts University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tufts University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tufts University, Deals By Therapy Area, 2011 to YTD 2017 8
Tufts University, Medical Devices Deals, 2011 to YTD 2017 9
Tufts University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tracon Pharma Enters into Research Agreement with Tufts Medical Center 11
Tufts Medical Center to Form Joint Venture with Lowell General Hospital 13
Tufts Medical Center Forms Joint Venture with Aton Partners 14
Pepticom Enters into Co-Development Agreement with Tufts Medical Center 15
Tufts Medical Center, Vanguard Health And New England Quality Care Partner For New Healthcare System 16
Arisaph Pharma Enters into Licensing Agreement with Tufts University 17
GliaCure Enters into Licensing Agreement with Tufts University 18
Tufts Medical Center Announces Public Offering Of Bonds For US$100 Million 19
Tufts University, Key Competitors 20
Tufts University, Key Employees 21
Tufts University, Subsidiaries 22

★海外企業調査レポート[Tufts University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Total Energy Services Inc (TOT):石油・ガス:M&Aディール及び事業提携情報
    Summary Total Energy Services Inc (Total Energy) is an energy services company. It offers contract drilling services and rental and transportation services for equipment utilized in drilling, completion and production activities in oil and gas wells. The company also provides fabrication, sale, rent …
  • AcelRx Pharmaceuticals Inc (ACRX):医療機器:M&Aディール及び事業提携情報
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes drugs for the treatment of pain. The company’s lead product candidate, Dsuvia (known as Dzuveo outside the US), is a single sufentanil sublingual tablet for the treatment of moderate-t …
  • Zain Group:企業の戦略・SWOT・財務分析
    Zain Group - Strategy, SWOT and Corporate Finance Report Summary Zain Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sinotrans Ltd:企業の戦略・SWOT・財務情報
    Sinotrans Ltd - Strategy, SWOT and Corporate Finance Report Summary Sinotrans Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Surgical Care Affiliates LLC (SCAI):企業の財務・戦略的SWOT分析
    Summary Surgical Care Affiliates LLC (SCA), a subsidiary of UnitedHealth Group Inc is a healthcare organization that offers patient care and healthcare services. The organization's services include scheduling optimization, physician governance and engagement, case costing, profitability analysis and …
  • Oil India Ltd (OIL)
    Oil India Ltd (OIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Brown Advisory Inc:企業の戦略・SWOT・財務分析
    Brown Advisory Inc - Strategy, SWOT and Corporate Finance Report Summary Brown Advisory Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Efore Oyj (EFO1V):企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Walchandnagar Industries Ltd:企業の戦略・SWOT・財務分析
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • China Pharma Holdings Inc (CPHI):企業の財務・戦略的SWOT分析
    China Pharma Holdings Inc (CPHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • StemCells, Inc.:企業のM&A・事業提携・投資動向
    StemCells, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's StemCells, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Adris grupa dd:企業の戦略・SWOT・財務分析
    Adris grupa dd - Strategy, SWOT and Corporate Finance Report Summary Adris grupa dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dowa Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Dowa Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Dowa Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Olam International Ltd:戦略・SWOT・企業財務分析
    Olam International Ltd - Strategy, SWOT and Corporate Finance Report Summary Olam International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Novacyt SA (ALNOV):医療機器:M&Aディール及び事業提携情報
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Biomerica Inc (BMRA):企業の製品パイプライン分析
    Summary Biomerica, Inc. (Biomerica) develops, manufactures, and markets medical diagnostic products used for the early detection and monitoring of chronic diseases and medical conditions. The company’s diagnostic test kits used to analyze blood, urine and fecal specimens of the patient to diagnose v …
  • FedEx Corporation (FDX):企業の財務・戦略的SWOT分析
    FedEx Corporation (FDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • AirAsia Berhad:企業のM&A・事業提携・投資動向
    AirAsia Berhad - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AirAsia Berhad Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • FuelCell Energy Inc (FCEL)-エネルギー分野:企業M&A・提携分析
    Summary FuelCell Energy, Inc. (FuelCell Energy) is an integrated fuel cell company that designs, manufactures, installs, operates, and services stationary fuel cell power plants for distributed power generation. It offers proprietary fuel cell products based on Direct FuelCell (DFC) carbonate fuel c …
  • Nissan Chemical Corp (4021):企業の財務・戦略的SWOT分析
    Nissan Chemical Corp (4021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆